Toward Quality Care in ADHD: Defining the Goals of Treatment
The DOI matches its Crossref record; 175 of the 175 references it cites were found in a registry or an index.
Abstract
Objective: Therapeutic goals for chronic mental disorders like major depressive disorder (MDD) and schizophrenia have evolved in parallel with the growing medical knowledge about the course and treatment of these disorders. Although the knowledge base regarding the clinical course of ADHD, a chronic psychiatric disorder, has evolved beyond symptomatic improvement and short-term treatment response, long-term goals, such as functional remission, have not yet been clearly defined. Method: A PubMed literature search was conducted to investigate the therapeutic goals of pharmacologic treatment referenced in the published literature from January 1998 through February 2010 using the following commonly used ADHD treatments as keywords: amphetamine, methylphenidate, atomoxetine, lisdexamfetamine, guanfacine, and clonidine. This search was then combined with an additional search that included the following outcome keywords: remission, relapse, remit, response, normal, normalization, recovery, and effectiveness. Results: Our search identified 102 publications. The majority (88.2% [90/102]) of these contained predefined criteria for treatment response. Predefined criteria for normalization and remission and/or relapse were presented in 4.9% (5/102), 12.7% (13/102), and 3.9% (4/102) of publications, respectively. There was a lack of consistency between the instruments used to measure outcomes as well as the criteria used to define treatment response, normalization, and remission as well as relapse. Conclusion: The therapeutic goals in treating ADHD should address optimal treatment outcomes that go beyond modest reductions of ADHD symptoms to include syndromatic, symptomatic, and functional remission. Future work should focus on reliable and valid tools to measure these outcomes in the clinical trial setting.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The efficacy of these treatments will be augmented by monitoring both symptomatic and functional outcomes and promotingadherence 151 .”
From Attention-deficit/hyperactivity disorder (2015) · cites this paper as [151]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders.
Widiger, T. A. (2000) · Encyclopedia of Psychology, Vol. 3. · doi:10.1037/10518-009 · Cited by 19,744
Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma
Program, P., & theDiagnosis, T. E. P. O. (1997) · Cited by 4,926
(1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.12.1073 · Cited by 3,372
Remission in Schizophrenia: Proposed Criteria and Rationale for Consensus
Andreasen, N. C., Carpenter, W. T., Kane, J. M., Lasser, R. A., Marder, S. R., & Weinberger, D. R. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.3.441 · Cited by 2,343
FARAONE, S. V., BIEDERMAN, J., & MICK, E. (2006) · Psychological Medicine · doi:10.1017/s003329170500471x · Cited by 2,267
Self-citationFrank, E. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810330075011 · Cited by 1,959 · cited 1×
“…have come to include the concept of remission and recovery, as well as freedom from impairment using well-defined criteria from diagnostic tools (American Psychiatric Association [APA], 1993; APA, 2000b; Andreasen et al., 2005; Depression Guideline Panel, 1993a, 1993b; Frank et al., 1991).”
MethodPearson, T. A., Blair, S. N., Daniels, S. R., Eckel, R. H., Fair, J. M., Fortmann, S. P., Franklin, B. A., Goldstein, L. B., Greenland, P., Grundy, S. M., et al. (2002) · Circulation · doi:10.1161/01.cir.0000020190.45892.75 · Cited by 1,854
Pliszka, S. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e318054e724 · Cited by 1,765
BARKLEY, R. A., FISCHER, M., EDELBROCK, C. S., & SMALLISH, L. (1990) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199007000-00007 · Cited by 1,507
Biederman, J. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.5.816 · Cited by 1,498 · cited 4×
“Biederman et al. (2000) use the term to indicate that the patient has fewer than half the symptoms required for a diagnosis.”
BackgroundMethodInfluentialSWANSON, J. M., KRAEMER, H. C., HINSHAW, S. P., ARNOLD, L. E., CONNERS, C. K., ABIKOFF, H. B., CLEVENGER, W., DAVIES, M., ELLIOTT, G. R., GREENHILL, L. L., et al. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200102000-00011 · Cited by 1,157 · cited 11×
“Four studies used a mean score of ≤1 on the SNAP-IV as the predefined criteria for remission (Greenhill et al., 2006; Steele, 2005; Steele Weiss et al., 2006; Swanson et al., 2001).”
BackgroundMethodResultInfluentialSelf-citationYoung Adult Outcome of Hyperactive Children: Adaptive Functioning in Major Life Activities
Barkley, R. A., Fischer, M., Smallish, L., & Fletcher, K. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000189134.97436.e2 · Cited by 1,027
ADHD Comorbidity Findings From the MTA Study: Comparing Comorbid Subgroups
JENSEN, P. S., HINSHAW, S. P., KRAEMER, H. C., LENORA, N., NEWCORN, J. H., ABIKOFF, H. B., MARCH, J. S., ARNOLD, L. E., CANTWELL, D. P., CONNERS, C. K., et al. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200102000-00009 · Cited by 974
Self-citationDistributed Disturbances in Brain Structure and Function in Schizophrenia
(2000) · American Journal of Psychiatry · doi:10.1176/ajp.157.1.1 · Cited by 969
Subcommittee on Attention-Deficit/Hyperactivity Disorder Committee on Quality Improvement (2001) · Pediatrics · doi:10.1542/peds.108.4.1033 · Cited by 878
Wilens, T. E., Faraone, S. V., Biederman, J., & Gunawardene, S. (2003) · Pediatrics · doi:10.1542/peds.111.1.179 · Cited by 872
Self-citationWEISS, G., HECHTMAN, L., MILROY, T., & PERLMAN, T. (1985) · Journal of the American Academy of Child Psychiatry · doi:10.1016/s0002-7138(09)60450-7 · Cited by 753
Attention deficit hyperactivity disorder adults: Comorbidities and adaptive impairments
Murphy, K., & Barkley, R. A. (1996) · Comprehensive Psychiatry · doi:10.1016/s0010-440x(96)90022-x · Cited by 700 · cited 1×
“…2006; Barkley, Guevremont, Anastopoulos, DuPaul, & Shelton, 1993; Fischer, Barkley, Smallish, & Fletcher, 2002; Mannuzza, Klein, Bessler, Malloy, & Hynes, 1997; Mitchell, Aman, Turbott, & Manku, 1987; Murphy & Barkley, 1996; Satterfield & Schell, 1997; G. Weiss, Hechtman, Milroy, & Perlman, 1985).”
Michelson, D., Faries, D., Wernicke, J., Kelsey, D., Kendrick, K., Sallee, F. R., Spencer, T., & the Atomoxetine ADHD Study Group (2001) · Pediatrics · doi:10.1542/peds.108.5.e83 · Cited by 666
(1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.12.1088 · Cited by 652
Michelson, D., Allen, A. J., Busner, J., Casat, C., Dunn, D., Kratochvil, C., Newcorn, J., Sallee, F. R., Sangal, R. B., Saylor, K., et al. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.11.1896 · Cited by 599 · cited 11×
“…& Dresel, 2005; Kuperman et al., 2001; Levin et al., 2006; Levin, Evans, Brooks, & Garawi, 2007; Loo, Teale, & Reite, 1999; Medori et al., 2008; Michelson et al., 2002; Mick, Biederman, Spencer, Faraone, & Sklar, 2006; Newcorn et al., 2006; Newcorn et al., 2008; Newcorn, Spencer,…”
MethodInfluentialJENSEN, P. S., HINSHAW, S. P., SWANSON, J. M., GREENHILL, L. L., CONNERS, C. K., ARNOLD, L. E., ABIKOFF, H. B., ELLIOTT, G., HECHTMAN, L., HOZA, B., et al. (2001) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/00004703-200102000-00008 · Cited by 591
Self-citationScahill, L., Chappell, P. B., Kim, Y. S., Schultz, R. T., Katsovich, L., Shepherd, E., Arnsten, A. F. T., Cohen, D. J., & Leckman, J. F. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.7.1067 · Cited by 588
(2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.11.1266 · Cited by 521
Pharmacotherapy of Attention-deficit/Hyperactivity Disorder Reduces Risk for Substance Use Disorder
Biederman, J., Wilens, T., Mick, E., Spencer, T., & Faraone, S. V. (1999) · Pediatrics · doi:10.1542/peds.104.2.e20 · Cited by 493
Self-citationEfficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD
GREENHILL, L., KOLLINS, S., ABIKOFF, H., MCCRACKEN, J., RIDDLE, M., SWANSON, J., MCGOUGH, J., WIGAL, S., WIGAL, T., VITIELLO, B., et al. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000235077.32661.61 · Cited by 467 · cited 3×
“…et al., 2006; Flapper & Schoemaker, 2008; Ghuman et al., 2001; Ghuman et al., 2009; Gibson, Bettinger, Patel, & Crismon, 2006; Gothelf et al., 2003; Greenhill et al., 2006; Greenhill, Findling, & Swanson, 2002; Greenhill, Newcorn, Gao, & Feldman, 2007; Greenhill, Wan, & Cooper, 2004; Grizenko,…”
MethodKelsey, D. K., Sumner, C. R., Casat, C. D., Coury, D. L., Quintana, H., Saylor, K. E., Sutton, V. K., Gonzales, J., Malcolm, S. K., Schuh, K. J., et al. (2004) · Pediatrics · doi:10.1542/peds.114.1.e1 · Cited by 464 · cited 3×
“…& Joober, 2006; Grizenko, Kovacina, et al., 2006; Handen, Feldman, Lurier, & Murray, 1999; Handen, Johnson, & Lubetsky 2000; Kaplan et al., 2004; Kelsey et al., 2004; Kemner, Starr, Ciccone, HooperWood, & Crockett, 2005; Kemner, Starr, Ciccone, & Lynch, 2004; Kowalik, Minami & Silva, 2006;…”
InfluentialSung, V., Hiscock, H., Sciberras, E., & Efron, D. (2008) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.162.4.336 · Cited by 404
Biederman, J., Krishnan, S., Zhang, Y., McGough, J. J., & Findling, R. L. (2007) · Clinical Therapeutics · doi:10.1016/s0149-2918(07)80083-x · Cited by 404
Barkley, R. A., Guevremont, D. C., Anastopoulos, A. D., DuPaul, G. J., & Shelton, T. L. (1993) · Pediatrics · doi:10.1542/peds.92.2.212 · Cited by 393
Spencer, T., Biederman, J., Wilens, T., Doyle, R., Surman, C., Prince, J., Mick, E., Aleardi, M., Herzig, K., & Faraone, S. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.043 · Cited by 385 · cited 1×
“…Sinzig et al., 2007; Spencer et al., 1998; Spencer, Biederman, Heiligenstein et al., 2001; Spencer , Biederman, Wilens et al., 2001; Spencer et al., 2002; Spencer et al., 2005; Spencer et al., 2007; Stein et al., 2003; Szobot, Ketzer, Parente, Biederman, & Rohde, 2004; Taylor & Russo, 2000;…”
Self-citationFischer, M., Barkley, R. A., Smallish, L., & Fletcher, K. (2002) · Journal of Abnormal Child Psychology · doi:10.1023/a:1019864813776 · Cited by 355
Newcorn, J. H., Kratochvil, C. J., Allen, A. J., Casat, C. D., Ruff, D. D., Moore, R. J., Michelson, D., & Atomoxetine/Methylphenidate Comparative Study Group (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.05091676 · Cited by 336 · cited 3×
“…Minami, & Silva, 2006; Kratochvil et al., 2001; Kratochvil et al., 2005; Kratochvil et al., 2007; Michelson et al., 2002; Newcorn et al., 2006; Newcorn et al., 2008; Newcorn, Spencer, Biederman, Milton, & Michelson, 2005; Prasad et al., 2007; Prasad & Steer, 2008; Ramoz et al., 2009;…”
InfluentialEffectiveness and Tolerability of Tomoxetine in Adults With Attention Deficit Hyperactivity Disorder
Spencer, T., Biederman, J., Wilens, T., Prince, J., Hatch, M., Jones, J., Harding, M., Faraone, S. V., & Seidman, L. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.5.693 · Cited by 335
Self-citationSpencer, T., Heiligenstein, J. H., Biederman, J., Faries, D. E., Kratochvil, C. J., Conners, C. K., & Potter, W. Z. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n1209 · Cited by 333 · cited 3×
“…Network, 2005; Sangal & Sangal, 2004, 2005, 2006; Scahill et al., 2001; Silva et al., 2004; Sinzig et al., 2007; Spencer, Biederman et al., 2001; Spencer et al., 2002; Stein et al., 2003; Szobot, Ketzer, Parente, Biederman, & Rohde, 2004; Trzepacz et al., 2008; M. Weiss et al., 2005; Wigal et…”
InfluentialEducational and Occupational Outcome of Hyperactive Boys Grown Up
MANNUZZA, S., KLEIN, R. G., BESSLER, A., MALLOY, P., & HYNES, M. E. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199709000-00014 · Cited by 328
Handen, B. L., Johnson, C. R., & Lubetsky, M. (2000) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1005548619694 · Cited by 326
Biederman, J., Melmed, R. D., Patel, A., McBurnett, K., Konow, J., Lyne, A., Scherer, N., & for the SPD503 Study Group (2008) · Pediatrics · doi:10.1542/peds.2006-3695 · Cited by 317 · cited 1×
“…et al., 2005; Armenteros, Lewis, & Davalos, 2007; Arnold et al., 2004; Bangs et al., 2007; Biederman, Krishnan, Zhang, McGough, & Findling, 2007; Biederman et al., 2008; Biederman, Spencer et al., 2007; Block et al., 2009; Buitelaar et al., 2007; Cheng, Chen, Ko, & Ng, 2007; Cheon, Cho, Koo,…”
MICHELSON, D., BUITELAAR, J. K., DANCKAERTS, M., GILLBERG, C., SPENCER, T. J., ZUDDAS, A., FARIES, D. E., ZHANG, S., & BIEDERMAN, J. (2004) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000125089.35109.81 · Cited by 307
Sallee, F. R., Lyne, A., Wigal, T., & McGough, J. J. (2009) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2008.0080 · Cited by 306
Multimodal Treatment of ADHD in the MTA: An Alternative Outcome Analysis
CONNERS, C. K., EPSTEIN, J. N., MARCH, J. S., ANGOLD, A., WELLS, K. C., KLARIC, J., SWANSON, J. M., ARNOLD, L. E., ABIKOFF, H. B., ELLIOTT, G. R., et al. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200102000-00010 · Cited by 285
Self-citationSATTERFIELD, J. H., & SCHELL, A. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199712000-00021 · Cited by 271
Bowden, C. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03480050135044 · Cited by 270
ADHD in Adults: What the Science Says
Trevino, J. J. (2008) · Psychiatric Services · doi:10.1176/appi.ps.59.9.1070 · Cited by 269
Biederman, J., Mick, E., Surman, C., Doyle, R., Hammerness, P., Harpold, T., Dunkel, S., Dougherty, M., Aleardi, M., & Spencer, T. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.011 · Cited by 267
Halperin, J. M., Trampush, J. W., Miller, C. J., Marks, D. J., & Newcorn, J. H. (2008) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2008.01926.x · Cited by 252
Spencer, T., Biederman, J., Wilens, T., Faraone, S., Prince, J., Gerard, K., Doyle, R., Parekh, A., Kagan, J., & Bearman, S. K. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.8.775 · Cited by 250
Self-citationDo Stimulants Protect Against Psychiatric Disorders in Youth With ADHD? A 10-Year Follow-up Study
Biederman, J., Monuteaux, M. C., Spencer, T., Wilens, T. E., & Faraone, S. V. (2009) · Pediatrics · doi:10.1542/peds.2008-3347 · Cited by 246
Self-citationClinical Characteristics and Serum Essential Fatty Acid Levels in Hyperactive Children
Mitchell, E. A., Aman, M. G., Turbott, S. H., & Manku, M. (1987) · Clinical Pediatrics · doi:10.1177/000992288702600805 · Cited by 246
Biederman, J., Monuteaux, M. C., Spencer, T., Wilens, T. E., MacPherson, H. A., & Faraone, S. V. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07091486 · Cited by 239
Self-citationThe effects of attention-deficit/hyperactivity disorder on employment and household income.
(2006) · PubMed Central · Cited by 238
Self-citationStein, M. A., Sarampote, C. S., Waldman, I. D., Robb, A. S., Conlon, C., Pearl, P. L., Black, D. O., Seymour, K. E., & Newcorn, J. H. (2003) · Pediatrics · doi:10.1542/peds.112.5.e404 · Cited by 231
Practice guideline for major depressive disorder in adults. American Psychiatric Association
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.4.1 · Cited by 226
Levin, F. R., Evans, S. M., Brooks, D. J., & Garawi, F. (2007) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2006.07.004 · Cited by 220
Adler, L. A., Goodman, D. W., Kollins, S. H., Weisler, R. H., Krishnan, S., Zhang, Y., & Biederman, J. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0903 · Cited by 218
Bush, G., Spencer, T. J., Holmes, J., Shin, L. M., Valera, E. M., Seidman, L. J., Makris, N., Surman, C., Aleardi, M., Mick, E., et al. (2008) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2007.16 · Cited by 201 · cited 1×
“…et al., 2007; Biederman Melmed et al., 2008; Biederman, Krishnan, Zhang, McGough, & Findling, 2007; Block et al., 2009; Buitelaar et al., 2007; Bush et al., 2008; Carpentier, de Jong, Dijkstra, Verbrugge, & Krabbe, 2005; Chacko et al., 2005; Cheng, Chen, Ko, & Ng, 2007; Cheon, Cho, Koo,…”
Medori, R., Ramos-Quiroga, J. A., Casas, M., Kooij, J. J. S., Niemelä, A., Trott, G.-E., Lee, E., & Buitelaar, J. K. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.11.008 · Cited by 186 · cited 3×
“Articles Containing Predefined Criteria for “Treatment Response” Abikoff et al., 2005; Adler, Goodman et al., 2008; Adler, Liebowitz et al., 2009; Ahmann et al., 2001; Armenteros, Lewis, & Davalos, 2007; Arnold et al., 2004; Bangs et al., 2007; Barkley, Guevremont, Anastopoulos, DuPaul, & Shelton, 1993; Biederman et a…”
Cheng, J. Y. W., Chen, R. Y. L., Ko, J. S. N., & Ng, E. M. L. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0840-x · Cited by 185 · cited 2×
“One study described the criteria for relapse prevention as a ≥25% reduction in ADHD-RS total score and CGI-S of ≤2 (Cheng et al., 2007).”
BackgroundResultGreenhill, L. L., Findling, R. L., Swanson, J. M., & MPH MR ADHD Study Group (2002) · PEDIATRICS · doi:10.1542/peds.109.3.e39 · Cited by 185
Reimherr, F. W., Williams, E. D., Strong, R. E., Mestas, R., Soni, P., & Marchant, B. K. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0113 · Cited by 180
TAYLOR, F. B., & RUSSO, J. (2000) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2000.10.311 · Cited by 180
Adler, L. A., Liebowitz, M., Kronenberger, W., Qiao, M., Rubin, R., Hollandbeck, M., Deldar, A., Schuh, K., & Durell, T. (2009) · Depression and Anxiety · doi:10.1002/da.20549 · Cited by 176
Newcorn, J. H., Spencer, T. J., Biederman, J., Milton, D. R., & Michelson, D. (2005) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200503000-00008 · Cited by 174
Remission versus response as the goal of therapy in ADHD: A new standard for the field?
Steele, M., Jensen, P. S., & Quinn, D. M. P. (2006) · Clinical Therapeutics · doi:10.1016/j.clinthera.2006.11.006 · Cited by 174
Self-citationLevin, F. R., Evans, S. M., Brooks, D. J., Kalbag, A. S., Garawi, F., & Nunes, E. V. (2006) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2005.06.012 · Cited by 173
Coghill, D. R., Rhodes, S. M., & Matthews, K. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.12.030 · Cited by 170
Wilens, T. E., Biederman, J., & Mick, E. (1998) · The American Journal on Addictions · doi:10.1111/j.1521-0391.1998.tb00330.x · Cited by 167
KOOIJ, J. J. S., BURGER, H., BOONSTRA, A. M., VAN DER LINDEN, P. D., KALMA, L. E., & BUITELAAR, J. K. (2004) · Psychological Medicine · doi:10.1017/s0033291703001776 · Cited by 163 · cited 1×
“…2000; Kaplan et al., 2004; Kelsey et al., 2004; Kemner, Starr, Ciccone, Hooper- Wood, & Crockett, 2005; Kemner, Starr, Ciccone, & Lynch, 2004; J. J. Kooij et al., 2004; J. S. Kooij et al., 2008; Kowalik, Minami, & Silva, 2006; Kratochvil et al., 2001; Kratochvil et al., 2005; Kratochvil et…”
Spencer, T. J., Adler, L. A., McGough, J. J., Muniz, R., Jiang, H., & Pestreich, L. K. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.07.032 · Cited by 162
Brown, T. E., & Landgraf, J. M. (2010) · Postgraduate Medicine · doi:10.3810/pgm.2010.09.2200 · Cited by 160 · cited 1×
“…et al., 2007; Adler et al., 2006; Adler, Spencer et al., 2008; Adler, Liebowitz et al., 2009; Adler, Spencer et al., 2009; Bastiaens, 2008; T. E. Brown & Landgraf, 2010; R. T. Brown, Perwien, Faries, Kratochvil, & Vaughan, 2006; Buitelaar et al., 2004; Buitelaar, Wilens, Zhang, Ning, & Feldman,…”
Wilens, T. E., McBurnett, K., Bukstein, O., McGough, J., Greenhill, L., Lerner, M., Stein, M. A., Conners, C. K., Duby, J., Newcorn, J., et al. (2006) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.160.1.82 · Cited by 160
Weisler, R. H., Biederman, J., Spencer, T. J., Wilens, T. E., Faraone, S. V., Chrisman, A. K., Read, S. C., & Tulloch, S. J. (2006) · CNS Spectrums · doi:10.1017/s1092852900013687 · Cited by 158 · cited 1×
“…et al., 2005; Spencer et al., 2007; Stein et al., 2003; Szobot, Ketzer, Parente, Biederman, & Rohde, 2004; Taylor & Russo, 2000; Trzepacz et al., 2008; Weisler et al., 2006; M. Weiss et al., 2005; M. Weiss & Hechtman, 2006; Wigal et al., 2004; Wilens McBurnett, Bukstein, McGough, Greenhill,…”
Self-citationon behalf of the study group, Rösler, M., Fischer, R., Ammer, R., Ose, C., & Retz, W. (2009) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-008-0845-4 · Cited by 155
Meta-Analysis of Suicide-Related Behavior Events in Patients Treated With Atomoxetine
BANGS, M. E., TAUSCHER-WISNIEWSKI, S., POLZER, J., ZHANG, S., ACHARYA, N., DESAIAH, D., TRZEPACZ, P. T., & ALLEN, A. J. (2008) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e31815d88b2 · Cited by 152
Kratochvil, C. J., Newcorn, J. H., Arnold, L. E., Duesenberg, D., Emslie, G. J., Quintana, H., Sarkis, E. H., Wagner, K. D., Gao, H., & Michelson, D. (2005) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000169012.81536.38 · Cited by 152 · cited 3×
“…2005; Kemner, Starr, Ciccone, & Lynch, 2004; J. J. Kooij et al., 2004; J. S. Kooij et al., 2008; Kowalik, Minami, & Silva, 2006; Kratochvil et al., 2001; Kratochvil et al., 2005; Kratochvil et al., 2007; Krause, la Fougere, Krause, Ackenheil, & Dresel, 2005; Kuperman et al., 2001; Levin et al.,…”
InfluentialSubstance Use among ADHD Adults: Implications of Late Onset and Subthreshold Diagnoses
Faraone, S. V., Wilens, T. E., Petty, C., Antshel, K., Spencer, T., & Biederman, J. (2007) · The American Journal on Addictions · doi:10.1080/10550490601082767 · Cited by 150
Self-citationAbikoff, H., McGough, J. J., Vitiello, B., McCracken, J. T., Davies, M., Walkup, J. T., Riddle, M. A., Oatis, M. D., Greenhill, L. L., Skrobala, A. M., et al. (2005) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000155320.52322.37 · Cited by 149
Blader, J. C., Schooler, N. R., Jensen, P. S., Pliszka, S. R., & Kafantaris, V. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09020233 · Cited by 149
Self-citationWeiss, M., Tannock, R., Kratochvil, C., Dunn, D., Velez-Borras, J., Thomason, C., Tamura, R., Kelsey, D., Stevens, L., & Allen, A. J. (2005) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000163280.47221.c9 · Cited by 147 · cited 6×
“…2005; Sangal & Sangal, 2004, 2005, 2006; Scahill et al., 2001; Spencer, Biederman, Heiligenstein et al., 2001; Spencer et al., 2002; Stein et al., 2003; Trzepacz et al., 2008; M. Weiss et al., 2005; Wigal et al., 2004; Wilens, McBurnett et al., 2006; Wilens, Kratochvil, Newcorn, & Gao, 2006.”
BackgroundMethodInfluentialSpencer, T., Biederman, J., Heiligenstein, J., Wilens, T., Faries, D., Prince, J., Faraone, S. V., Rea, J., Witcher, J., & Zervas, S. (2001) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/10445460152595577 · Cited by 147
Self-citationAdler, L. A., Spencer, T., Brown, T. E., Holdnack, J., Saylor, K., Schuh, K., Trzepacz, P. T., Williams, D. W., & Kelsey, D. (2009) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318192e4a0 · Cited by 142
Efficacy of Methylphenidate Among Preschool Children With Developmental Disabilities and ADHD
Handen, B. L., Feldman, H. M., Lurier, A., & Murray, P. J. (1999) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199907000-00009 · Cited by 128
Armenteros, J. L., Lewis, J. E., & Davalos, M. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e3180323354 · Cited by 127
MATZA, L. S., RENTZ, A. M., SECNIK, K., SWENSEN, A. R., REVICKI, D. A., MICHELSON, D., SPENCER, T., NEWCORN, J. H., & KRATOCHVIL, C. J. (2004) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/00004703-200406000-00005 · Cited by 119 · cited 1×
“…Cutler, & Hodgkins, 2005; Gurkan et al., 2010; Karpenko, Owens, Evangelista, & Dodds, 2009; Manos, Frazier, Landgraf, Weiss, & Hodgkins, 2009; Matza et al., 2004; Matza, Johnston, Faries, Malley, & Brod, 2007; Matza, Stoeckl, Shorr, & Johnston, 2006; Maziade et al., 2009; Michelson et al.,…”
Abikoff, H. B., Vitiello, B., Riddle, M. A., Cunningham, C., Greenhill, L. L., Swanson, J. M., Chuang, S. Z., Davies, M., Kastelic, E., Wigal, S. B., et al. (2007) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2007.0068 · Cited by 118 · cited 2×
“Articles Referencing the Functional and Quality-of-Life Outcomes in Children and Adults With ADHD Using Both General Assessment Scales and Disease-Specific Measures Abikoff et al., 2007; Adler et al., 2006; Adler, Spencer et al., 2008; Adler, Liebowitz et al., 2009; Adler, Spencer et al., 2009; Bastiaens, 2008; T. E.…”
BackgroundBupropion SR vs. Methylphenidate vs. Placebo for Attention Deficit Hyperactivity Disorder in Adults
Kuperman, S., Perry, P., Gaffney, G., Lund, B., Bever-Stille, K., Arndt, S., Holman, T., Moser, D., & Paulsen, J. (2001) · Annals of Clinical Psychiatry · doi:10.3109/10401230109148958 · Cited by 113
Biederman, J., Spencer, T. J., Newcorn, J. H., Gao, H., Milton, D. R., Feldman, P. D., & Witte, M. M. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0565-2 · Cited by 110
Weiss, M., Hechtman, L., & The Adult ADHD Research Group (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0412 · Cited by 108
Faraone, S. V., Biederman, J., Spencer, T., Michelson, D., Adler, L., Reimherr, F., & Glatt, S. J. (2005) · Behavioral and Brain Functions · doi:10.1186/1744-9081-1-16 · Cited by 108
Self-citationAdler, L. A., Zimmerman, B., Starr, H. L., Silber, S., Palumbo, J., Orman, C., & Spencer, T. (2009) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181a390ce · Cited by 106
The Atomoxetine ADHD and Comorbid MDD Study Group:, Bangs, M. E., Emslie, G. J., Spencer, T. J., Ramsey, J. L., Carlson, C., Bartky, E. J., Busner, J., Duesenberg, D. A., Harshawat, P., et al. (2007) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2007.0066 · Cited by 103 · cited 3×
“Abikoff et al., 2005; Armenteros, Lewis, & Davalos, 2007; Arnold et al., 2004; Bangs et al., 2007; Biederman, Krishnan, Zhang, McGough, & Findling, 2007; Biederman et al., 2008; Biederman, Spencer et al., 2007; Block et al., 2009; Buitelaar et al., 2007; Cheng, Chen, Ko, & Ng, 2007; Cheon, Cho,…”
BackgroundLong-term atomoxetine treatment in adolescents with attention-deficit/hyperactivity disorder
Wilens, T. E., Newcorn, J. H., Kratochvil, C. J., Gao, H., Thomason, C. K., Rogers, A. K., Feldman, P. D., & Levine, L. R. (2006) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2006.01.052 · Cited by 102
WIGAL, S., SWANSON, J. M., FEIFEL, D., SANGAL, R. B., ELIA, J., CASAT, C. D., ZELDIS, J. B., & CONNERS, C. K. (2004) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000138351.98604.92 · Cited by 101 · cited 5×
“…2005; Sangal & Sangal, 2004, 2005, 2006; Scahill et al., 2001; Spencer, Biederman, Heiligenstein et al., 2001; Spencer et al., 2002; Stein et al., 2003; Trzepacz et al., 2008; M. Weiss et al., 2005; Wigal et al., 2004; Wilens, McBurnett et al., 2006; Wilens, Kratochvil, Newcorn, & Gao, 2006.”
InfluentialKemner, J. E., Starr, H. L., Ciccone, P. E., Hooper-Wood, C. G., & Crockett, R. S. (2005) · Advances in Therapy · doi:10.1007/bf02849870 · Cited by 99
Prasad, S., Harpin, V., Poole, L., Zeitlin, H., Jamdar, S., Puvanendran, K., & on behalf of the SUNBEAM Study Group (2007) · Current Medical Research and Opinion · doi:10.1185/030079906x167309 · Cited by 97 · cited 4×
“…et al., 2008; Newcorn, Spencer, Biederman, Milton, & Michelson, 2005; Nikles, Mitchell, Del Mar, Clavarino, & McNairn, 2006; Perwien et al., 2006; Prasad et al., 2007; Prasad & Steer, 2008; Ramoz et al., 2009; Research Units on Pediatric Psychopharmacology Autism Network, 2005; Sangal &…”
BackgroundInfluentialMick, E., Faraone, S. V., Spencer, T., Zhang, H. F., & Biederman, J. (2008) · Journal of Attention Disorders · doi:10.1177/1087054707308468 · Cited by 95
Self-citationMcGough, J. J., Biederman, J., Wigal, S. B., López, F. A., McCracken, J. T., Spencer, T. J., Zhang, Y., & Tulloch, S. J. (2005) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000157550.94702.a2 · Cited by 95
Functional Outcomes in the Treatment of Adults With ADHD
Adler, L. A., Spencer, T. J., Levine, L. R., Ramsey, J. L., Tamura, R., Kelsey, D., Ball, S. G., Allen, A. J., & Biederman, J. (2008) · Journal of Attention Disorders · doi:10.1177/1087054707308490 · Cited by 93
EEG correlates of methylphenidate response among children with ADHD: a preliminary report
Loo, S. K., Teale, P. D., & Reite, M. L. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00250-9 · Cited by 92
Carpentier, P. J., De Jong, C. A. J., Dijkstra, B. A. G., Verbrugge, C. A. G., & Krabbe, P. F. M. (2005) · Addiction · doi:10.1111/j.1360-0443.2005.01272.x · Cited by 91
Findling, R. L., Childress, A. C., Krishnan, S., & McGough, J. J. (2008) · CNS Spectrums · doi:10.1017/s1092852900016898 · Cited by 90
Ghuman, J. K., Aman, M. G., Lecavalier, L., Riddle, M. A., Gelenberg, A., Wright, R., Rice, S., Ghuman, H. S., & Fort, C. (2009) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2008.0137 · Cited by 90
Buitelaar, J. K., Michelson, D., Danckaerts, M., Gillberg, C., Spencer, T. J., Zuddas, A., Faries, D. E., Zhang, S., & Biederman, J. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.066 · Cited by 89
Response to methylphenidate in boys with attention-deficit hyperactivity disorder
Zeiner, P., Bryhn, G., Bjercke, C., Truyen, K., & Strand, G. (1999) · Acta Paediatrica · doi:10.1080/08035259950170060 · Cited by 87
Gothelf, D., Gruber, R., Presburger, G., Dotan, I., Brand-Gothelf, A., Burg, M., Inbar, D., Steinberg, T., Frisch, A., Apter, A., et al. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n1004 · Cited by 86
Atomoxetine Versus Stimulants for Treatment of Attention Deficit/Hyperactivity Disorder
Gibson, A. P., Bettinger, T. L., Patel, N. C., & Crismon, M. L. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1g582 · Cited by 85
Krause, J., la Fougere, C., Krause, K.-H., Ackenheil, M., & Dresel, S. H. (2005) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-005-0602-x · Cited by 84
Buitelaar, J. K., Danckaerts, M., Gillberg, C., Zuddas, A., Becker, K., Bouvard, M. P., Fagan, J., Gádoros, J., Harpin, V., Hazell, P., et al. (2004) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-004-0401-3 · Cited by 82
Normalized functioning in youths with persistent attention-deficit/hyperactivity disorder
Biederman, J., Mick, E. O., & Faraone, S. V. (1998) · The Journal of Pediatrics · doi:10.1016/s0022-3476(98)70065-4 · Cited by 80
Self-citationAdler, L. A., Sutton, V. K., Moore, R. J., Dietrich, A. P., Reimherr, F. W., Sangal, R. B., Saylor, K. E., Secnik, K., Kelsey, D. K., & Allen, A. J. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000239797.21826.70 · Cited by 79 · cited 1×
“…Quality-of-Life Outcomes in Children and Adults With ADHD Using Both General Assessment Scales and Disease-Specific Measures Abikoff et al., 2007; Adler et al., 2006; Adler, Spencer et al., 2008; Adler, Liebowitz et al., 2009; Adler, Spencer et al., 2009; Bastiaens, 2008; T. E. Brown & Landgraf,…”
BackgroundSpencer, T. J., Adler, L. A., Weisler, R. H., & Youcha, S. H. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0911 · Cited by 79
Response to methylphenidate in adults with ADHD is associated with a polymorphism in SLC6A3 (DAT1)
Kooij, J. S., Boonstra, A. M., Vermeulen, S. H., Heister, A. G., Burger, H., Buitelaar, J. K., & Franke, B. (2008) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30586 · Cited by 79
Nikles, C. J., Mitchell, G. K., Del Mar, C. B., Clavarino, A., & McNairn, N. (2006) · Pediatrics · doi:10.1542/peds.2005-1328 · Cited by 78
Flapper, B. C., & Schoemaker, M. M. (2008) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.2008.02039.x · Cited by 75
Perwien, A. R., Kratochvil, C. J., Faries, D. E., Vaughan, B. S., Spencer, T., & Brown, R. T. (2006) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2006.16.713 · Cited by 74 · cited 5×
“Articles Containing Predefined Criteria for “Treatment Response” Abikoff et al., 2005; Adler, Goodman et al., 2008; Adler, Liebowitz et al., 2009; Ahmann et al., 2001; Armenteros, Lewis, & Davalos, 2007; Arnold et al., 2004; Bangs et al., 2007; Barkley, Guevremont, Anastopoulos, DuPaul, & Shelton, 1993; Biederman et a…”
InfluentialSvanborg, P., Thernlund, G., Gustafsson, P. A., Hägglöf, B., Poole, L., & Kadesjö, B. (2009) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-008-0725-5 · Cited by 71
CYP2D6 metabolizer status and atomoxetine dosing in children and adolescents with ADHD
Trzepacz, P. T., Williams, D. W., Feldman, P. D., Wrishko, R. E., Witcher, J., & Buitelaar, J. K. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.06.002 · Cited by 71
ADORE ? Attention?Deficit Hyperactivity Disorder Observational Research in Europe
Ralston, S. J., Lorenzo, M. J., & and the ADORE study group (2004) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-004-1004-8 · Cited by 70
Responsiveness of the Adult Attention-Deficit/Hyperactivity Disorder Quality of Life Scale (AAQoL)
Matza, L. S., Johnston, J. A., Faries, D. E., Malley, K. G., & Brod, M. (2007) · Quality of Life Research · doi:10.1007/s11136-007-9254-9 · Cited by 69
Chacko, A., Pelham, W., Gnagy, E., Greiner, A. R., Vallano, G., Bukstein, O., & Rancurello, M. (2005) · Journal of the American Academy of Child and Adolescent Psychiatry · doi:10.1097/00004583-200503000-00009 · Cited by 67
Kaplan, S., Heiligenstein, J., West, S., Busner, J., Harder, D., Dittmann, R., Casat, C., & Wernicke, J. F. (2004) · Journal of Attention Disorders · doi:10.1177/108705470400800202 · Cited by 66
Findling, R. L., Quinn, D., HATCH, S. J., Cameron, S. J., DeCory, H. H., & McDowell, M. (2006) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-006-0565-0 · Cited by 64
Ahmann, P. A., Theye, F. W., Berg, R., Linquist, A. J., Van Erem, A. J., & Campbell, L. R. (2001) · Pediatrics · doi:10.1542/peds.107.1.e10 · Cited by 64
Grizenko, N., Bhat, M., Schwartz, G., Ter-Stepanian, M., & Joober, R. (2006) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0606 · Cited by 64
Sinzig, J., Döpfner, M., Lehmkuhl, G., & German Methylphenidate Study Group (2007) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2007.0011 · Cited by 62
Do Children and Adolescents With ADHD Respond Differently to Atomoxetine?
Wilens, T. E., Kratochvil, C., Newcorn, J. H., & Gao, H. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000190352.90946.0b · Cited by 59 · cited 1×
“…Biederman et al., 2001; Spencer et al., 2002; Stein et al., 2003; Szobot, Ketzer, Parente, Biederman, & Rohde, 2004; Trzepacz et al., 2008; M. Weiss et al., 2005; Wigal et al., 2004; Wilens et al., 2006; Wilens, Kratochvil, Newcorn, & Gao, 2006; Zeiner, Bryhn, Bjercke, Truyen, & Strand, 1999.”
Ramoz, N., Boni, C., Downing, A. M., Close, S. L., Peters, S. L., Prokop, A. M., Allen, A. J., Hamon, M., Purper‐Ouakil, D., & Gorwood, P. A. P. M. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.39 · Cited by 59
Maziade, M., Rouleau, N., Lee, B., Rogers, A., Davis, L., & Dickson, R. (2009) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2008.0166 · Cited by 57
Aripiprazole in Children with Attention-Deficit/Hyperactivity Disorder
Findling, R. L., Short, E. J., Leskovec, T. J., Townsend, L. D., Demeter, C., McNamara, N., & Stansbrey, R. J. (2007) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2007.0124 · Cited by 56
Brown, R. T., Perwien, A., Faries, D. E., Kratochvil, C. J., & Vaughan, B. S. (2006) · Clinical Pediatrics · doi:10.1177/0009922806294219 · Cited by 56
Dell'Agnello, G., Maschietto, D., Bravaccio, C., Calamoneri, F., Masi, G., Curatolo, P., Besana, D., Mancini, F., Rossi, A., Poole, L., et al. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.07.008 · Cited by 54
GHUMAN, J. K., Ginsburg, G. S., Subramaniam, G., Ghuman, H. S., Kau, A. S. M., & Riddle, M. A. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200105000-00010 · Cited by 54
Ramos-Quiroga, J. A., Bosch, R., Castells, X., Valero, S., Nogueira, M., Gómez, N., Yelmo, S., Ferrer, M., Martínez, Y., & Casas, M. (2008) · CNS Drugs · doi:10.2165/00023210-200822070-00005 · Cited by 54 · cited 4×
“Articles Containing Predefined Criteria for “Treatment Response” Abikoff et al., 2005; Adler, Goodman et al., 2008; Adler, Liebowitz et al., 2009; Ahmann et al., 2001; Armenteros, Lewis, & Davalos, 2007; Arnold et al., 2004; Bangs et al., 2007; Barkley, Guevremont, Anastopoulos, DuPaul, & Shelton, 1993; Biederman et a…”
InfluentialDepression in Primary Care: Volume 2.: Treatment of Major Depression
(1993) · PsycEXTRA Dataset · doi:10.1037/e530172011-001 · Cited by 54
An Open-Label Trial of Tomoxetine in Pediatric Attention Deficit Hyperactivity Disorder
Kratochvil, C. J., Bohac, D., Harrington, M., Baker, N., May, D., & Burke, W. J. (2001) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/104454601750284072 · Cited by 53
Medications Do Not Necessarily Normalize Cognition in ADHD Patients
Gualtieri, C. T., & Johnson, L. G. (2008) · Journal of Attention Disorders · doi:10.1177/1087054707305314 · Cited by 53
Block, S. L., Kelsey, D., Coury, D., Lewis, D., Quintana, H., Sutton, V., Schuh, K., Allen, A. J., & Sumner, C. (2009) · Clinical Pediatrics · doi:10.1177/0009922809335321 · Cited by 53 · cited 3×
“…2007; Arnold et al., 2004; Bangs et al., 2007; Biederman, Krishnan et al., 2007; Biederman Spencer et al., 2007; Biederman Melmed et al., 2008; Block et al., 2009; Buitelaar et al., 2007; Chacko et al., 2005; Cheng, Chen, Ko, & Ng, 2007; Cheon, Cho, Koo, Song, & Namkoong, 2009; Coghill,…”
InfluentialArnold, L. E., Lindsay, R. L., Conners, C. K., Wigal, S. B., Levine, A. J., Johnson, D. E., West, S. A., Sangal, R. B., Bohan, T. P., & Zeldis, J. B. (2004) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2004.14.542 · Cited by 51
Svanborg, P., Thernlund, G., Gustafsson, P. A., Hägglöf, B., Schacht, A., & Kadesjö, B. (2009) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-009-0031-x · Cited by 51
Mick, E., Biederman, J., Spencer, T., Faraone, S. V., & Sklar, P. (2006) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30376 · Cited by 51
Self-citationKarpenko, V., Owens, J. S., Evangelista, N. M., & Dodds, C. (2009) · Journal of Clinical Psychology · doi:10.1002/jclp.20549 · Cited by 50
Grizenko, N., Kovacina, B., Amor, L. B., Schwartz, G. J., Ter-Stepanian, M., & Joober, R. (2005) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000184932.64294.d9 · Cited by 50
Escobar, R., Montoya, A., Polavieja, P., Cardo, E., Artigas, J., Hervas, A., & Fuentes, J. (2009) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2008.0109 · Cited by 48
Hoare, P. G., Remschmidt, H., Medori, R., Ettrich, C., Rothenberger, A., Santosh, P., Schmit, M., Spender, Q., Tamhne, R. C., Thompson, M. J. J., et al. (2005) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-005-0486-3 · Cited by 46
Gürkan, K., Bilgiç, A., Türkoğlu, S., Kılıç, B. G., Aysev, A., & Uslu, R. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881109348172 · Cited by 44
Buitelaar, J. K., Wilens, T. E., Zhang, S., Ning, Y., & Feldman, P. D. (2009) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2008.01960.x · Cited by 41
Spencer, T. J., Landgraf, J. M., Adler, L. A., Weisler, R. H., Anderson, C. S., & Youcha, S. H. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n1112 · Cited by 39 · cited 3×
“Articles Containing Predefined Criteria for “Treatment Response” Abikoff et al., 2005; Adler, Goodman et al., 2008; Adler, Liebowitz et al., 2009; Ahmann et al., 2001; Armenteros, Lewis, & Davalos, 2007; Arnold et al., 2004; Bangs et al., 2007; Barkley, Guevremont, Anastopoulos, DuPaul, & Shelton, 1993; Biederman et a…”
BackgroundFindling, R. L., Wigal, S. B., Bukstein, O. G., Boellner, S. W., Abikoff, H., Turnbow, J. M., & Civil, R. (2009) · Clinical Therapeutics · doi:10.1016/j.clinthera.2009.08.002 · Cited by 39
Yoo, H. K., Park, S., Wang, H., Lee, J. S., Kim, K., Paik, K., Yum, M. S., & Ko, T. (2009) · Epileptic Disorders · doi:10.1684/epd.2009.0278 · Cited by 39
Goodman, D. W., Ginsberg, L., Weisler, R. H., Cutler, A. J., & Hodgkins, P. (2005) · CNS Spectrums · doi:10.1017/s1092852900002418 · Cited by 39
Prasad, S., & Steer, C. (2008) · Pediatric Drugs · doi:10.2165/00148581-200810010-00005 · Cited by 38
Cheon, K.-A., Cho, D.-Y., Koo, M.-S., Song, D.-H., & Namkoong, K. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.12.003 · Cited by 38
Faraone, S. V., Short, E. J., Biederman, J., Findling, R. L., Roe, C., & Manos, M. J. (2002) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145702002845 · Cited by 38
Self-citationHigh-Dose Atomoxetine Treatment of ADHD in Youths With Limited Response to Standard Doses
Kratochvil, C. J., Michelson, D., Newcorn, J. H., Weiss, M. D., Busner, J., Moore, R. J., Ruff, D. D., RAMSEY, J., Dickson, R. A., Turgay, A., et al. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e318074eeb3 · Cited by 37
Greenhill, L. L., Newcorn, J. H., Gao, H., & Feldman, P. D. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e3180335ad1 · Cited by 36
Low-Dose Atomoxetine for Maintenance Treatment of Attention-Deficit/Hyperactivity Disorder
Newcorn, J. H., Michelson, D., Kratochvil, C. J., Allen, A. J., Ruff, D. D., Moore, R. J., & for the Atomoxetine Low-dose Study Group (2006) · Pediatrics · doi:10.1542/peds.2005-2999 · Cited by 34
Sangal, R. B., & Sangal, J. M. (2006) · Clinical Neurophysiology · doi:10.1016/j.clinph.2006.06.004 · Cited by 34
Achieving Remission as a Routine Goal of Pharmacotherapy in Attention-Deficit Hyperactivity Disorder
Ramos-Quiroga, J. A., & Casas, M. (2011) · CNS Drugs · doi:10.2165/11538450-000000000-00000 · Cited by 33
Jensen, P. S. (1999) · The Canadian Journal of Psychiatry · doi:10.1177/070674379904401003 · Cited by 32
Self-citationSangal, J. M., & Sangal, R. B. (2003) · Clinical Neurophysiology · doi:10.1016/j.clinph.2003.08.023 · Cited by 30
Wehmeier, P. M., Dittmann, R. W., Schacht, A., Minarzyk, A., Lehmann, M., Sevecke, K., & Lehmkuhl, G. (2007) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2007.0025 · Cited by 30
Manos, M., Frazier, T. W., Landgraf, J. M., Weiss, M., & Hodgkins, P. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990903388797 · Cited by 30
Cannon, M., Pelham, W. H., Sallee, F. R., Palumbo, D. R., Bukstein, O., & Daviss, W. B. (2009) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2009.0008 · Cited by 29
GW320659 for the Treatment of Attention-Deficit/Hyperactivity Disorder in Children
DeVeaugh-Geiss, J., Conners, C. K., Sarkis, E. H., Winner, P. K., Ginsberg, L. D., Hemphill, J. M., Laurenza, A., BARROWS, C. F., WEBSTER, C. J., STOTKA, C. J., et al. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200208000-00009 · Cited by 29
Szobot, C. M., Ketzer, C., Parente, M. A., Biederman, J., & Rohde, L. A. (2004) · Journal of Attention Disorders · doi:10.1177/108705470400800201 · Cited by 29
Weiss, M., Hechtman, L., Turgay, A., Jain, U., Quinn, D., Ahmed, T. S., Yates, T., Reiz, J. L., Donnelly, G. A. E., Harsanyi, Z., et al. (2007) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2006.0101 · Cited by 26
Bastiaens, L. (2008) · Psychiatric Quarterly · doi:10.1007/s11126-008-9070-6 · Cited by 25
A Postmarketing Clinical Experience Study of Metadate® CD
Dirksen, S. J. H., D'Imperio, J. M., Birdsall, D., & HATCH, S. J. (2002) · Current Medical Research and Opinion · doi:10.1185/030079902125001100 · Cited by 24
Sangal, R. B., & Sangal, J. M. (2004) · Clinical Neurophysiology · doi:10.1016/j.clinph.2004.09.028 · Cited by 23
Impact of atomoxetine on health-related quality of life and functional status in patients with ADHD
Matza, L. S., Stoeckl, M. N., Shorr, J. M., & Johnston, J. A. (2006) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/14737167.6.4.379 · Cited by 22
Durell, T. M., Pumariega, A. J., Rothe, E. M., Tamayo, J. M., Baron, D., & Williams, D. (2009) · Annals of Clinical Psychiatry · doi:10.1177/104012370902100104 · Cited by 19
Silva, R., Tilker, H. A., Cecil, J. T., Kowalik, S., Khetani, V., Faleck, H., & Patin, J. (2004) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2004.14.555 · Cited by 18
The Drug-Placebo Response Curve: A New Method for Assessing Drug Effects in Clinical Trials
Faraone, S. V., Biederman, J., Spencer, T. J., & Wilens, T. E. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200012000-00014 · Cited by 17
Self-citationKowalik, S. C., Minami, H., & Silva, R. (2006) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.7.18.2547 · Cited by 10
ADHD in adults: what the science says
(2008) · Choice Reviews Online · doi:10.5860/choice.45-5266
Research works printed but not linked: 10
- Biederman J., 2006, MedGenMed: Medscape General Medicine, 8, 12
- Depression Guideline Panel, 1993, Depression in primary care: Volume 1, diagnosis and detection
- Greenhill L. L., 2004, Paper presented at the American Psychiatric Association 2004 Annual Meeting
- Grizenko N., 2006, Journal of Psychiatry & Neuroscience, 31, 46
- Kemner J. E., 2004, Paper presented at the American Psychiatric Association 2004 Annual Meeting
- 10.1097/chi.0b013e318054e724 · DOI · Paper page
- Steele M., 2005, Paper presented at the American Psychiatric Association 2005 Annual Meeting
- Steele M., 2006, Canadian Journal of Clinical Pharmacology, 13, e50
- Wilens T. E., 1998, American Journal of Addiction, 7, 156
- 10.1111/j.1651-2227.1999.tb01100.x · DOI · Paper page
Cited by
Attention-deficit/hyperactivity disorder
Faraone, S. V., Asherson, P., Banaschewski, T., Biederman, J., Buitelaar, J. K., Ramos-Quiroga, J. A., Rohde, L. A., Sonuga-Barke, E. J. S., Tannock, R., & Franke, B. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.20 · Cited by 1,479
Self-citationAttention-deficit/hyperactivity disorder
Faraone, S. V., Bellgrove, M. A., Brikell, I., Cortese, S., Hartman, C. A., Hollis, C., Newcorn, J. H., Philipsen, A., Polanczyk, G. V., Rubia, K., et al. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00495-0 · Cited by 355
Self-citationChildress, A. C., & Sallee, F. R. (2014) · CNS Drugs · doi:10.1007/s40263-013-0130-6 · Cited by 98
“[20] defined functional remission as ‘‘having both symptom scores and functioning within the”
BackgroundPadilha, S. C., Virtuoso, S., Tonin, F. S., Borba, H. H. L., & Pontarolo, R. (2018) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-018-1125-0 · Cited by 73
Is camouflaging unique for autism? A comparison of camouflaging between adults with autism and ADHD
van der Putten, W. J., Mol, A. J. J., Groenman, A. P., Radhoe, T. A., Torenvliet, C., van Rentergem, J. A. A., & Geurts, H. M. (2024) · Autism Research · doi:10.1002/aur.3099 · Cited by 54
Metadata
- Authors
- Rostain, A., Jensen, P. S., Connor, D. F., Miesle, L. M., & Faraone, S. V.
- Affiliations
- University of Pennsylvania Health System (US)
- Mayo Clinic (US)
- University of Connecticut (US)
- Plymouth City Council (GB)
- SUNY Upstate Medical University (US)
- Venue
- Journal of Attention Disorders
- Publisher
- SAGE Publications
- Published
- 2013-02-19
- Volume
- 19
- Issue
- 2
- Pages
- 99-117
- ISSN
- 1087-0547 (ISSN-L)
- 1557-1246
- OpenAlex
- W2152960279
- Cited by
- 33
- References
- 175
- Citations by year
- 2025: 1 · 2024: 4 · 2023: 4 · 2022: 2 · 2021: 1 · 2020: 5 · 2019: 1 · 2018: 1 · 2017: 4 · 2015: 4 · 2014: 5 · 2013: 1
- FWCI
- 0.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Attention Disorders (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Massachusetts General Hospital
- National Institutes of Health
- U.S. Food and Drug Administration
- State University of New York Upstate Medical University
- National Institute of Mental Health
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- attention deficit hyperactivity disorder, treatment goals, functional remission, relapse, treatment response criteria, outcome measures, stimulant pharmacotherapy, amphetamine, methylphenidate, atomoxetine, lisdexamfetamine, guanfacine, clonidine, chronic mental illness
- MeSH terms
- Atomoxetine Hydrochloride, Lisdexamfetamine Dimesylate, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Dextroamphetamine, Goals, Humans, Methylphenidate, Propylamines, Quality of Health Care, Guanfacine, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.